Symptom Severity and Exclusion From Antidepressant Efficacy Trials
Abstract
It is the standard practice in antidepressant efficacy trials (AETs) to exclude potential participants with major depressive disorder (MDD) who score below a threshold on the Hamilton Rating Scale for Depression (HAM-D). It is unknown to what extent various cutoff scores impact on the generalizability of these trials. In the present report, we sought to determine how many patients with MDD presenting to an outpatient practice would fail to qualify for an AET because their symptoms were not sufficiently severe, and to what extent the variability in HAM-D cutoff scores impacts exclusion rates. Fifteen hundred individuals presenting for an intake at a psychiatric outpatient practice underwent an evaluation with semistructured diagnostic interviews. Five hundred and three patients received a principal diagnosis of nonbipolar, nonpsychotic MDD. Thirty-nine AETs published in five leading journals during the past 7 years were reviewed, 36 of which required a minimum score on the HAM-D for inclusion. We applied the HAM-D cutoffs used in these AETs to the 503 depressed patients to determine how many would qualify for each AET. Based on the least and most restrictive cutoff scores, between 11.3% and 71.0% of the depressed patients from our practice had an insufficient HAM-D score to qualify for an AET. The two most commonly used cutoff scores would lead to the exclusion of almost half of our sample. AETs tend to include the subset of depressed individuals with moderate to severe MDD and exclude a significant proportion of depressed patients who have mild MDD. The implications of these findings are discussed.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Most patients with depression report symptoms below the threshold for severe depression.
“This is concerning considering that most patients with depression report symptoms below the threshold for severe depression.12 13”
Cites
Endicott, J. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310043002 · Cited by 5,686 · see citing works
Hamilton Depression Rating Scale
Endicott, J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260100011 · Cited by 427 · see citing works
Double-blind treatment of major depression with dehydroepiandrosterone.
Wolkowitz, O. M., Reus, V. I., Keebler, A., Nelson, N., Friedland, M., Brizendine, L., & Roberts, E. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.4.646 · Cited by 411 · see citing works
Elkin, I., Gibbons, R. D., Shea, M. T., Sotsky, S. M., Watkins, J. T., Pilkonis, P. A., & Hedeker, D. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.63.5.841 · Cited by 317 · see citing works
Elkin, I., Gibbons, R. D., Shea, M. T., Sotsky, S. M., Watkins, J. T., Pilkonis, P. A., & Hedeker, D. (1995) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.63.5.841 · Cited by 317 · see citing works
Psychiatric diagnosis in clinical practice: Is comorbidity being missed?
Zimmerman, M. A., & Mattia, J. I. (1999) · Comprehensive Psychiatry · doi:10.1016/s0010-440x(99)90001-9 · Cited by 316 · see citing works
Self-citationBondareff, W., Alpert, M., Friedhoff, A. J., Richter, E. M., Clary, C. M., & Batzar, E. D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.729 · Cited by 202 · see citing works
Differences Between Clinical and Research Practices in Diagnosing Borderline Personality Disorder
Zimmerman, M., & Mattia, J. I. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.10.1570 · Cited by 199 · see citing works
Self-citationMulticenter, Placebo-Controlled, Fixed-Dose Study of Citalopram in Moderate-to-Severe Depression
Feighner, J. P., & Overø, K. F. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n1204 · Cited by 169 · see citing works
A Double-Blind Comparison of Sertraline and Fluoxetine in Depressed Elderly Outpatients
Newhouse, P. A., Krishnan, K. R. R., Doraiswamy, P. M., Richter, E. M., Batzar, E. D., & Clary, C. M. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0804 · Cited by 163 · see citing works
The Treatment of Chronic Depression, Part 2
Keller, M. B., Gelenberg, A. J., Hirschfeld, R. M. A., Rush, A. J., Thase, M. E., Kocsis, J. H., Markowitz, J. C., FAWCETT, J. A., Koran, L. M., Klein, D. N., et al. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n1107 · Cited by 161 · see citing works
Mirtazapine Compared With Paroxetine in Major Depression
Benkert, O., Szegedi, A., & Kohnen, R. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0911 · Cited by 159 · see citing works
Wheatley, D. P., Moffaert, M. V., Timmerman, L., & Kremer, C. M. E. (1998) · PubMed · Cited by 157 · see citing works
A Comparison of Venlafaxine, Trazodone, and Placebo in Major Depression
Cunningham, L. A., Borison, R. L., Carman, J. S., Chouinard, G., Crowder, J. E., Diamond, B. I., FISCHER, D. E., & HEARST, E. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199404000-00003 · Cited by 157 · see citing works
Bupropion Sustained Release Versus Paroxetine for the Treatment of Depression in the Elderly
Weihs, K. L., Settle, E. C., Batey, S. R., Houser, T. L., Donahue, R. M. J., & Ascher, J. A. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0309 · Cited by 150 · see citing works
Double-Blind Comparison of Bupropion Sustained Release and Sertraline in Depressed Outpatients
Kavoussi, R. J., Segraves, R. T., Hughes, A. R., Ascher, J. A., & Johnston, J. A. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1204 · Cited by 149 · see citing works
Wheatley, D. P., van Moffaert, M., Timmerman, L., Kremer, C. M. E., & The Mirtazapine-Fluoxetine Study Group (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0606 · Cited by 145 · see citing works
Rudolph, R. L., Fabre, L. F., Feighner, J. P., Rickels, K., Entsuah, R., & Derivan, A. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0305 · Cited by 132 · see citing works
Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
Schweizer, E. E., Feighner, J. P., Mandos, L. A., & Rickels, K. (1994) · PubMed · Cited by 128 · see citing works
Dexamethasone for the treatment of depression: a randomized, placebo- controlled, double-blind trial
Arana, G. W., Santos, A. B., Laraia, M. T., McLeod-Bryant, S., Beale, M. D., Rames, L. J., Roberts, J. M., Dias, J. K., & Molloy, M. A. (1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.2.265 · Cited by 127 · see citing works
Lydiard, R. B., Stahl, S. M., Hertzman, M., & Harrison, W. M. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n1104 · Cited by 126 · see citing works
A double-blind comparison of nefazodone, imipramine, and placebo in major depression.
Fontaine, R., Ontiveros, A., Elie, R., Kensler, T. T., Roberts, D. L., Kaplita, S., Ecker, J., & Faludi, G. (1994) · PubMed · Cited by 117 · see citing works
Comparison of Bupropion and Trazodone for the Treatment of Major Depression
Weisler, R. H., Johnston, J., Lineberry, C. G., Samara, B., Branconnier, R. J., & Billow, A. A. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199406000-00004 · Cited by 107 · see citing works
Bennie, E. H., Mullin, J. M., & Martindale, J. J. (1995) · PubMed · Cited by 105 · see citing works
Thase, M. E., & The Venlafaxine XR 209 Study Group (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0904 · Cited by 105 · see citing works
Mehtonen, O. ‐., Søgaard, J., Roponen, P., Behnke, K., & Venlafaxine 631 Study Group (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n0204 · Cited by 97 · see citing works
Silva, J. C. E. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0703 · Cited by 95 · see citing works
A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
Bremner, J. D. (1995) · PubMed · Cited by 92 · see citing works
A Double-Blind Comparison of Fluvoxamine and Paroxetine in the Treatment of Depressed Outpatients
Kiev, A., & Feiger, A. D. (1997) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v58n0402 · Cited by 89 · see citing works
Are Tricyclic Antidepressants Useful for Mild Depression? A Placebo controlled Trial
Paykel, E. S., FREELING, P., & Hollyman, J. A. (1988) · Pharmacopsychiatry · doi:10.1055/s-2007-1014639 · Cited by 74 · see citing works
Valproate as an antidepressant in major depressive disorder.
Davis, L. L., Kabel, D., Patel, D., Choate, A., Foslien-Nash, C., Gurguis, G. N. M., Kramer, G. L., & Petty, F. (1996) · PubMed · Cited by 69 · see citing works
Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression.
Dunlop, S. R., Dornseif, B. E., Wernicke, J., & Potvin, J. H. (1990) · PubMed · Cited by 59 · see citing works
Concerns About Clinical Drug Trials
Robinson, D. S., & Rickels, K. (2000) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200012000-00001 · Cited by 58 · see citing works
Fluvoxamine Maleate in the Treatment of Depression
Claghorn, J. L., Earl, C. Q., Walczak, D. D., Stoner, K. A., Wong, L. F., Kanter, D. R., & Houser, V. P. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199604000-00003 · Cited by 54 · see citing works
PREDICTORS OF RESPONSE TO AMITRIPTYLINE AND PLACEBO IN THREE OUTPATIENT TREATMENT SETTINGS
Downing, R. W., & Rickels, K. (1973) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197302000-00004 · Cited by 53 · see citing works
Angst, J., Bech, P., Boyer, P., et al. (1989) · Pharmacopsychiatry · doi:10.1055/s-2007-1014568 · Cited by 53 · see citing works
Severity of depression and response to fluoxetine
Pande, A. C., & Sayler, M. E. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300840-00006 · Cited by 51 · see citing works
Cs, W., Jm, F., Jl, D., & Heiser, J. F. (1996) · PubMed · Cited by 51 · see citing works
Can mildly depressed outpatients with atypical depression benefit from antidepressants?
Stewart, J. W., McGrath, P. J., & Quitkin, F. M. (1992) · American Journal of Psychiatry · doi:10.1176/ajp.149.5.615 · Cited by 50 · see citing works
A Comparison of Fluvoxamine and Fluoxetine in the Treatment of Major Depression
Rapaport, M. H., Coccaro, E. F., Sheline, Y. I., Perse, T., Holland, P. J., Fabre, L. F., & Bradford, D. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199610000-00005 · Cited by 49 · see citing works
Buspirone and Imipramine for the Treatment of Major Depression in the Elderly
Schweizer, E. E., Rickels, K., Hassman, H. H., & García‐España, F. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0406 · Cited by 48 · see citing works
TOLLEFSON, G. D., GREIST, J. H., JEFFERSON, J. W., HEILIGENSTEIN, J. H., SAYLER, M. E., TOLLEFSON, S. L., & KOBACK, K. (1994) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199412000-00003 · Cited by 47 · see citing works
Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
Niklson, I. A., Reimitz, P., & Sennef, C. (1997) · PubMed · Cited by 34 · see citing works
Suri, R., Altshuler, L. L., Rasgon, N. L., Calcagno, J. L., Frye, M. A., Gitlin, M. J., Hwang, S., & Zuckerbrow-Miller, J. (2000) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v61n1209 · Cited by 31 · see citing works
Ad, F. (1996) · PubMed · Cited by 28 · see citing works
Lapierre, Y. D., Silverstone, P. H., Reesal, R. T., Saxena, B. M., Turner, P., Bakish, D., Plamondon, J., Vincent, P. M., Remick, R. A., Kroft, C. D. L., et al. (1998) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199808000-00002 · Cited by 22 · see citing works
Rapaport, M. H., Zisook, S., Frevert, T., Seymour, S., Kelsoe, J. R., & Judd, L. L. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199606000-00009 · Cited by 20 · see citing works
Zalospirone in Major Depression
Rickels, K., Derivan, A., Kunz, N. R., Pallay, A., & Schweizer, E. E. (1996) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199606000-00004 · Cited by 20 · see citing works
Moclobemide and placebo in mild major depression: a double-blind randomized trial
Ose, E., & Holm, P. (1992) · Psychopharmacology · doi:10.1007/bf02246251 · Cited by 17 · see citing works
Miller, C. A., Cl, H., & Bakish, D. (1997) · PubMed · Cited by 11 · see citing works
Ferguson, J. M., MENDELS, J., & Manowitz, N. R. (1994) · PubMed · Cited by 10 · see citing works
Once-Versus Twice-Daily Venlafaxine Therapy in Major Depression
Amsterdam, J. D., Hooper, M. B., & Amchin, J. (1998) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v59n0506 · Cited by 8 · see citing works
Desipramine Versus Phenelzine in Recurrent Unipolar Depression
Swann, A. C., Bowden, C. L., Rush, A. J., Rhoades, H. M., Rose, R., & Kobes, R. D. (1997) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199704000-00002 · Cited by 8 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Antidepressant Drug Effects and Depression Severity: A Patient-Level Meta-analysis
Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010) · JAMA · doi:10.1001/jama.2009.1943 · Cited by 2,009 · see citing works
Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60046-5 · Cited by 1,654 · see citing works
Zimmerman, M., Chelminski, I., & Posternak, M. A. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1370 · Cited by 144 · see citing works
Self-citationRecchia, F., Leung, C. K., Chin, E. C., Fong, D. Y., Montero, D., Cheng, C. P., Yau, S. Y., & Siu, P. M. (2022) · British Journal of Sports Medicine · doi:10.1136/bjsports-2022-105964 · Cited by 117 · see citing works
The generalizability of antidepressant efficacy trials to routine psychiatric out-patient practice
van der Lem, R., van der Wee, N. J. A., van Veen, T., & Zitman, F. G. (2011) · Psychological Medicine · doi:10.1017/s0033291710002175 · Cited by 63 · see citing works
van der Lem, R., van der Wee, N. J. A., van Veen, T., & Zitman, F. G. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000330890 · Cited by 63 · see citing works
A critical review of pharmacotherapy for major depressive disorder.
Dupuy, J. M., Ostacher, M. J., Huffman, J., Perlis, R. H., & Nierenberg, A. A. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000083 · Cited by 61 · see citing works
‘They won't do any harm and might do some good’: time to think again on the use of antidepressants?
Middleton, H., & Moncrieff, J. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x548983 · Cited by 36 · see citing works
Outcome in depression (II): beyond the Hamilton Depression Rating Scale
Demyttenaere, K., Kiekens, G., Bruffaerts, R., Mortier, P., Gorwood, P., Martin, L., & Di Giannantonio, M. (2021) · CNS Spectrums · doi:10.1017/s109285292000142x · Cited by 16 · see citing works
Cavanah, A. M., Robinson, L. A., Mattingly, M. L., & Frugé, A. D. (2025) · Biomedicines · doi:10.3390/biomedicines13071656 · Cited by 7 · see citing works
“This has been proven to be somewhat problematic, as antidepressants have been found to be less useful in cases of mild to moderate depression, which constitutes the majority of individuals with depression [5].”
- Authors
- Zimmerman, M., Posternak, M. A., & Chelminski, I.
- Affiliations
- Brown University (US)
- ORCID
- Zimmerman, Mark
- Venue
- Journal of Clinical Psychopharmacology
- Published
- 2002-12
- Volume
- 22
- Issue
- 6
- Pages
- 610-614
- ISSN
- 0271-0749 (ISSN-L)
- OpenAlex
- W2333091096
- Cited by
- 49
- References
- 53
- Citations by year
- 2025: 3 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 4 · 2018: 1 · 2017: 1 · 2016: 2 · 2015: 2 · 2014: 4 · 2013: 3 · 2012: 5
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29mh048732-05)
- National Institute of Mental Health (MH48732)
- Topics
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
- Keywords
- major depressive disorder, symptom severity, Hamilton Depression Rating Scale, mild depression, generalizability of trial results
- MeSH terms
- Adult, Antidepressive Agents, Clinical Trials as Topic, Major Depressive Disorder, Female, Humans, Interview, Psychological, Male, Outpatients, Psychiatric Status Rating Scales, Sampling Studies, Severity of Illness Index, Patient Selection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review